27 May

Medtronic Has Guided for a Modest Revenue Performance in 2020

WRITTEN BY Margaret Patrick

Revenue guidance

In its fiscal 2019 fourth-quarter earnings investor presentation, Medtronic (MDT) guided for YoY (year-over-year) organic revenue growth of +/- 4% for fiscal 2020. Assuming constant foreign exchange rates, the company has estimated a negative YoY revenue impact of 1.0%–1.5% for fiscal 2020. Based on these revenue growth projections, the company has guided for revenue in the range of +/- $31.3 billion–$31.5 billion for fiscal 2020.

On its fourth-quarter earnings conference call, Medtronic guided for YoY organic revenue growth of 2%–2.5% and a negative revenue impact due to foreign exchange at a current rate of 2.1%–2.6% in the first quarter of fiscal 2020. Medtronic expects to report lower-than-normal sequential revenue growth in the first quarter of fiscal 2020. According to its fourth-quarter earnings conference call, this projection is partly based on its stronger-than-expected revenue performance in the fourth quarter of fiscal 2019 and the ongoing uncertainty associated with paclitaxel-coated balloons in its peripheral business.

Medtronic Has Guided for a Modest Revenue Performance in 2020

Further, temporary challenges associated with the shutdown of a facility of one of Medtronic’s minimally invasive therapies group business’s key sterilization suppliers is also expected to have a detrimental impact on the company’s first-quarter revenue performance. To learn more about the regulatory challenges faced by Medtronic’s paclitaxel-coated balloons business, read A Look at Boston Scientific’s Gross Margin in 2019.

Wall Street estimates

Medtronic reported revenue of $30.56 billion, a YoY rise of 5.5% on an organic basis, ahead of the guidance of 4.0%–4.5% it provided for fiscal 2019.

Analysts expect Medtronic’s revenue to see YoY rises of 3.04% to $31.49 billion in fiscal 2020, 4.63% to $32.94 billion in fiscal 2021, and 4.94% to $34.57 billion in fiscal 2022.

Analysts also expect Medtronic’s revenue to see YoY rises of 0.27% to $7.40 billion in the first quarter, 2.23% to $7.65 billion in the second quarter, 3.81% to $7.83 billion in the third quarter, and 4.69% to $8.53 billion in the fourth quarter of fiscal 2020.

Latest articles

Some options traders are betting large, bullish bets in favor of Disney stock and Disney+ in particular. Let’s take a closer look at the options.

Yesterday, Canopy Growth (CGC) and Aurora Cannabis reported their earnings. Let's look at the valuation multiples of these two prominent cannabis players.

Mid-tier department store chain JCPenney (JCP) impressed investors by reporting a lower-than-anticipated loss for the third quarter of fiscal 2019.

On November 14, Carl Icahn's Icahn Capital Management filed its form 13F. In the third quarter, it included two new stocks.

Dish Network reported Q3 revenues of $3.17 billion, down 6.7% year-over-year. Dish reported adjusted earnings per share of $0.66—down 19.5% YoY.

It’s been quite the whipsaw week for cannabis stocks, to put it mildly. First, there was the “Drake spike.” Then came the earnings disappointments.